NCT04413019

Brief Summary

This study is designed to compare efficacy \& safety of planned domiciliary versus hospital care for women with preterm prelabor rupture of the membranes (PPROM) on fetal, neonatal and maternal outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,662

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 29, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 2, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2020

Completed
Last Updated

January 6, 2021

Status Verified

January 1, 2021

Enrollment Period

1.5 years

First QC Date

May 29, 2020

Last Update Submit

January 4, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Take-home baby

    this outcome is the best indicator of success of the management plan when the outcome is alive \& well baby

    2 years

Study Arms (2)

Group (D): Planned domiciliary care.

Patients within this group will be counseled for home care with self-monitoring for any symptoms suggestive of preterm labor, maternal or fetal distress.

Other: Clinical follow up

Group (H): Planned hospital care.

Patients within this group will be admitted at hospital for close monitoring of maternal \& fetal wellbeing \& finally the neonatal outcome

Other: Clinical follow up

Interventions

Patients recruited in this study commenced antibiotic treatment according to the recent guidelines : * Erythromycin 250 mg 4 times daily for 10 days following the diagnosis of PPROM, or until the women is established labor (whichever sooner) * Penicillin may be used in patients who can't tolerate erythromycin * In cases of penicillin allergy: Cefazolin 1 g intravenously every 8 hours for 48 hours, followed by cephalexin 500 mg orally four times daily for five days. These drugs provide coverage for both GBS and Escherichia coli, the two major causes of neonatal infection.

Group (D): Planned domiciliary care.Group (H): Planned hospital care.

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant women with rupture of the fetal membranes before 37 weeks of gestation
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will include 3662 women with a history of preterm prelabor rupture of the membranes

You may not qualify if:

  • Query PPROM: A history of PPROM with no pooling of amniotic fluid from the cervix on a sterile speculum examination
  • Maternal comorbidities (Diabetes mellitus, hypertension, etc.)
  • Patients with placenta previa
  • Amniotic fluid pocket on ultrasound \< 2x2 cm
  • Logistic problems interfering with follow-up
  • Inability to check temperature every six hours, with parameters for notifying their clinician (temperature ≥38°C)
  • Non-Dependable transportation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine - Ain Shams university

Cairo, 11517, Egypt

Location

MeSH Terms

Conditions

Preterm Premature Rupture of the Membranes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
ASelim

Study Record Dates

First Submitted

May 29, 2020

First Posted

June 2, 2020

Study Start

April 15, 2019

Primary Completion

October 1, 2020

Study Completion

October 20, 2020

Last Updated

January 6, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will share

all statistical methods, results of the study ,discussion \& recommendations

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
onset of January, 2022 (6 months after publication)
Access Criteria
sponsor e.mail \& the sponsor organisation
More information

Locations